FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W768201224> ?p ?o ?g. }

• W768201224 endingPage "e0131278" @default.
• W768201224 startingPage "e0131278" @default.
• W768201224 abstract "Whether a combination of chemotherapy and erlotinib is beneficial for advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to summarize the currently available evidence and compare the efficacy and safety of chemotherapy plus erlotinib versus chemotherapy alone for treating advanced NSCLC.EMBASE, PubMed, and the Cochrane Central Register of Controlled Trials were searched for relevant studies. Our protocol was registered in PROSPERO (CRD42014015015).Nine randomized controlled trials with a total of 3599 patients were included. Compared to chemotherapy alone, chemotherapy plus erlotinib was superior in PFS (HR = 0.76 [95% CI 0.62, 0.92], P = 0.006), and no statistically significant difference was observed in OS (HR = 0.94 [95% CI 0.86, 1.03], P = 0.16). Intercalated erlotinib plus chemotherapy demonstrated improvements in PFS (HR = 0.67 [95% CI 0.50, 0.91], P = 0.009) and OS (HR = 0.82 [95% CI 0.69, 0.98], P = 0.03). Continuous erlotinib plus chemotherapy treatment failed to demonstrate improvements in PFS (HR = 0.91 [95% CI 0.80, 1.04], P = 0.16) and OS (HR = 0.98 [95% CI 0.89, 1.09], P = 0.75). The association of chemotherapy plus erlotinib with improvement in PFS was significant in never smoking patients (HR = 0.46 [95% CI 0.37, 0.56], P<0.00001) but not in smoking patients (HR = 0.70 [95% CI 0.49, 1.00], P = 0.05). Among patients with EGFR mutant tumors, chemotherapy plus erlotinib demonstrated significant improvements in PFS (HR = 0.31 [95% CI 0.17, 0.58], P = 0.0002) and OS (HR = 0.52 [95% CI 0.30, 0.88], P = 0.01). Among patients with EGFR wild-type tumors, no statistically significant difference was observed with respect to PFS (HR = 0.87 [95% CI 0.70, 1.08], P = 0.21) and OS (HR = 0.78 [95% CI 0.59, 1.01], P = 0.06).Combination of chemotherapy and erlotinib is a viable treatment option for patients with NSCLC, especially for patients who never smoked and patients with EGFR mutation-positive disease. In addition, intercalated administration is an effective combinatorial strategy." @default.
• W768201224 created "2016-06-24" @default.
• W768201224 creator A5007212885 @default.
• W768201224 creator A5011230183 @default.
• W768201224 creator A5011854155 @default.
• W768201224 creator A5024147822 @default.
• W768201224 creator A5028624269 @default.
• W768201224 creator A5029710781 @default.
• W768201224 creator A5058563343 @default.
• W768201224 date "2015-07-06" @default.
• W768201224 modified "2023-10-03" @default.
• W768201224 title "Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis" @default.
• W768201224 cites W1500599576 @default.
• W768201224 cites W1982328899 @default.
• W768201224 cites W1995559542 @default.
• W768201224 cites W2005501262 @default.
• W768201224 cites W2019331695 @default.
• W768201224 cites W2028863990 @default.
• W768201224 cites W2038989435 @default.
• W768201224 cites W2042278676 @default.
• W768201224 cites W2057936937 @default.
• W768201224 cites W2073456167 @default.
• W768201224 cites W2083404706 @default.
• W768201224 cites W2083896010 @default.
• W768201224 cites W2084437976 @default.
• W768201224 cites W2086584802 @default.
• W768201224 cites W2088095316 @default.
• W768201224 cites W2088371419 @default.
• W768201224 cites W2089913598 @default.
• W768201224 cites W2106787323 @default.
• W768201224 cites W2116827288 @default.
• W768201224 cites W2117316096 @default.
• W768201224 cites W2124967121 @default.
• W768201224 cites W2129904284 @default.
• W768201224 cites W2134964659 @default.
• W768201224 cites W2138297714 @default.
• W768201224 cites W2138410640 @default.
• W768201224 cites W2142850084 @default.
• W768201224 cites W2144330816 @default.
• W768201224 cites W2152755651 @default.
• W768201224 cites W2160982674 @default.
• W768201224 cites W2161817637 @default.
• W768201224 cites W2162724777 @default.
• W768201224 cites W4238604577 @default.
• W768201224 cites W768201224 @default.
• W768201224 doi "https://doi.org/10.1371/journal.pone.0131278" @default.
• W768201224 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4493135" @default.
• W768201224 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26147288" @default.
• W768201224 hasPublicationYear "2015" @default.
• W768201224 type Work @default.
• W768201224 sameAs 768201224 @default.
• W768201224 citedByCount "19" @default.
• W768201224 countsByYear W7682012242015 @default.
• W768201224 countsByYear W7682012242016 @default.
• W768201224 countsByYear W7682012242017 @default.
• W768201224 countsByYear W7682012242018 @default.
• W768201224 countsByYear W7682012242019 @default.
• W768201224 countsByYear W7682012242020 @default.
• W768201224 countsByYear W7682012242021 @default.
• W768201224 countsByYear W7682012242022 @default.
• W768201224 countsByYear W7682012242023 @default.
• W768201224 crossrefType "journal-article" @default.
• W768201224 hasAuthorship W768201224A5007212885 @default.
• W768201224 hasAuthorship W768201224A5011230183 @default.
• W768201224 hasAuthorship W768201224A5011854155 @default.
• W768201224 hasAuthorship W768201224A5024147822 @default.
• W768201224 hasAuthorship W768201224A5028624269 @default.
• W768201224 hasAuthorship W768201224A5029710781 @default.
• W768201224 hasAuthorship W768201224A5058563343 @default.
• W768201224 hasBestOaLocation W7682012241 @default.
• W768201224 hasConcept C121608353 @default.
• W768201224 hasConcept C126322002 @default.
• W768201224 hasConcept C143998085 @default.
• W768201224 hasConcept C2776256026 @default.
• W768201224 hasConcept C2776694085 @default.
• W768201224 hasConcept C2778087573 @default.
• W768201224 hasConcept C2779438470 @default.
• W768201224 hasConcept C2909325608 @default.
• W768201224 hasConcept C71924100 @default.
• W768201224 hasConceptScore W768201224C121608353 @default.
• W768201224 hasConceptScore W768201224C126322002 @default.
• W768201224 hasConceptScore W768201224C143998085 @default.
• W768201224 hasConceptScore W768201224C2776256026 @default.
• W768201224 hasConceptScore W768201224C2776694085 @default.
• W768201224 hasConceptScore W768201224C2778087573 @default.
• W768201224 hasConceptScore W768201224C2779438470 @default.
• W768201224 hasConceptScore W768201224C2909325608 @default.
• W768201224 hasConceptScore W768201224C71924100 @default.
• W768201224 hasIssue "7" @default.
• W768201224 hasLocation W7682012241 @default.
• W768201224 hasLocation W7682012242 @default.
• W768201224 hasLocation W7682012243 @default.
• W768201224 hasLocation W7682012244 @default.
• W768201224 hasLocation W7682012245 @default.
• W768201224 hasOpenAccess W768201224 @default.
• W768201224 hasPrimaryLocation W7682012241 @default.
• W768201224 hasRelatedWork W1667731616 @default.
• W768201224 hasRelatedWork W2053686268 @default.

• next